Future Infectious Disease Nucleic Acid Testing


February 14, 2012
360 Pages - SKU: VPG6809702
License type:
This 360-page report presents an overview of the clinical significance and market needs for major infectious diseases, as well as extensive listings of companies developing and marketing molecular diagnostic technologies and products.

Contains 360 pages and 20 tables

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.



More Antisense & RNAi Technology reports by Venture Planning Group

Analysis of Nucleic Acid Testing Technologies And Strategic Profiles of Leading Suppliers by Venture Planning Group
This 180-page report provides detailed analyses of current and emerging nucleic acid testing technologies, and their potential market applications, including DNA sequencing, RNA probes, detection ...
Analysis of Nucleic Acid Testing Instrumentation And Strategic Profiles of Leading Suppliers by Venture Planning Group
This 103-page report is designed to help suppliers identify and evaluate emerging opportunities for further automating NAT methods in order to facilitate their penetration into ...
Analysis of Emerging Nucleic Acid Testing Assays And Strategic Profiles of Leading Suppliers by Venture Planning Group
This 549-page report presents an overview of the clinical significance and market needs for major current and emerging NAT assays, as well as extensive listings ...
Analysis of the World Nucleic Acid Testing Market Sales Forecasts by Country and Strategic Profiles of Leading Suppliers by Venture Planning Group
This report provides a worldwide overview of the nucleic acid testing market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well ...
See all reports like this >>